Dividend stocks have been potent wealth escalators for nearly a century. Pfizer, a high-yield pharma stock, has sold off over the prior 12 months, creating a compelling buying opportunity for ...
Despite a 50% stock decline, I remain bullish on GigaCloud Technology due to strong business performance and tempting valuation. GCT's Q3 results showed 70% revenue growth and a 47% EPS beat, driven ...
In the coming weeks, I plan on boosting my position in Amazon by around 20%. Amazon's net sales, diluted EPS, and operating cash flow each surged higher in Q2. The company's net cash position ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback